We are developing microfluidic concepts and lab-on-a-chip systems for life sciences applications to (a) advance precision medicine, (b) facilitate quality control of biopharmaceutical products, and (c) reduce animal testing. Our research strategy brings together relevant engineering, analytical and biomedical expertise with the aim of bridging the “research-to-product gaps” in microfluidics, lab-on-a-chip systems, and organ-on-a-chip technology.
